BETA nonprofit public democratic european moderated

Search

#HIVPrevention
R
Reuters 4w

Since its launch in June, the usage of Gilead Sciences' Yeztugo, a twice-yearly injection for HIV prevention, has increased, but many patients face challenges such as insurance coverage gaps and a preference for daily pills over the injectable option. #HIVPrevention #PrEP #HealthcareAccess #US

Focus: Use of Gilead's HIV prevention shot rises, but US insurance gaps remain